Pharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOHSENI SHAHRZAD; TABATABAEI MALAZY OZRA; BANDARIAN FATEMEH; LARIJANI BAGHER

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Koomesh Year:2022 | Volume:24 | Issue:2 (88) Page(s): 183-190

Download Full-Text

Persian Verion

View:

Download:

Cites:

Information Journal Paper

Title

Pharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review

Author(s)

MOHSENI SHAHRZAD | TABATABAEI MALAZY OZRA | BANDARIAN FATEMEH | LARIJANI BAGHER | Issue Writer Certificate

Keywords

Sulfonylurea Compounds

Glibenclamide

Diabetes Mellitus

Pharmacogenomics

Precision Medicine

Abstract

Introduction: One of the most widely used anti-diabetic drugs is sulfonylureas, which is often used as one of the first-line drugs in the treatment of type 2 diabetes. Due to the effect of the patient's genetic structure on the drug response (personalized medicine), the identification of genetic variations not only reduces the rate of adverse drug reactions but can also predict the effectiveness of drugs. This study aimed to systematically review the Pharmacogenomics of Glibenclamide in type 2 diabetes. Materials and Methods: This systematic review was performed based on PRISMA flowchart. Using the search terms including "variant", “, sulfonylurea”, , "Glibenclamide", "Diabetes Mellitus", "SNP" or their equivalents, a comprehensive search of the PubMed, Scopus and Web of Science databases was conducted until January 1, 2021. An initial search yielded 125 articles. Results: Finally, in nine articles included in this systematic review, Glibenclamide monotherapy was performed in 3032 patients. Most studies were conducted in China and the most common methods of genotyping were RFLP-PCR and direct sequencing. The most common genes studied were CYP2C9, KCNJ11 and TCF7L2. The results of studies showed a significant effect of CYP2C9 polymorphism on appropriate therapeutic response and KCNJ11 gene polymorphism on failure of Glibenclamide treatment. Conclusion: Among all genetic factors and specific genotypes of proteins involved in the metabolism of Glibenclamide, CYP2C9 gene polymorphism has a role in proper response to treatment and KCNJ11 gene polymorphism has a role in treatment failure and hypoglycemic effects of Glibenclamide.

Cites

No record.

References

No record.

Cite

APA: Copy

MOHSENI, SHAHRZAD, TABATABAEI MALAZY, OZRA, BANDARIAN, FATEMEH, & LARIJANI, BAGHER. (2022). Pharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review. KOOMESH, 24(2 (88) ), 183-190. SID. https://sid.ir/paper/1058623/en

Vancouver: Copy

MOHSENI SHAHRZAD, TABATABAEI MALAZY OZRA, BANDARIAN FATEMEH, LARIJANI BAGHER. Pharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review. KOOMESH[Internet]. 2022;24(2 (88) ):183-190. Available from: https://sid.ir/paper/1058623/en

IEEE: Copy

SHAHRZAD MOHSENI, OZRA TABATABAEI MALAZY, FATEMEH BANDARIAN, and BAGHER LARIJANI, “Pharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review,” KOOMESH, vol. 24, no. 2 (88) , pp. 183–190, 2022, [Online]. Available: https://sid.ir/paper/1058623/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops